BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34182228)

  • 21. Antigenicity of
    Fernández L; Carrillo E; Sánchez-Sampedro L; Sánchez C; Ibarra-Meneses AV; Jimenez MA; Almeida VDA; Esteban M; Moreno J
    Front Immunol; 2018; 9():843. PubMed ID: 29740446
    [No Abstract]   [Full Text] [Related]  

  • 22. Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8
    Rodrigues LS; Barreto AS; Bomfim LGS; Gomes MC; Ferreira NLC; da Cruz GS; Magalhães LS; de Jesus AR; Palatnik-de-Sousa CB; Corrêa CB; de Almeida RP
    Front Immunol; 2021; 12():773983. PubMed ID: 34777391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis.
    Chamizo C; Moreno J; Alvar J
    Vet Immunol Immunopathol; 2005 Jan; 103(1-2):67-75. PubMed ID: 15626462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after
    Rodrigues-Neto JF; Monteiro GR; Keesen TSL; Lacerda HG; Carvalho EM; Jeronimo SMB
    Am J Trop Med Hyg; 2018 Mar; 98(3):875-882. PubMed ID: 29280433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.
    Resende LA; Aguiar-Soares RD; Gama-Ker H; Roatt BM; Mendonça LZ; Alves ML; Silveira-Lemos Dd; Corrêa-Oliveira R; Martins-Filho OA; Araújo MS; Fujiwara RT; Gontijo NF; Reis AB; Giunchetti RC
    PLoS One; 2016; 11(8):e0161169. PubMed ID: 27556586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.
    Pinelli E; Gonzalo RM; Boog CJ; Rutten VP; Gebhard D; del Real G; Ruitenberg EJ
    Eur J Immunol; 1995 Jun; 25(6):1594-600. PubMed ID: 7614987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum.
    Santos-Gomes GM; Rosa R; Leandro C; Cortes S; Romão P; Silveira H
    Vet Immunol Immunopathol; 2002 Sep; 88(1-2):21-30. PubMed ID: 12088641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular apoptosis and nitric oxide production in PBMC and spleen from dogs with visceral leishmaniasis.
    de Martini CC; de Andrade JT; de Almeida SKM; Oliveira Silva KL; de Rezende Eugenio F; Dos Santos PSP; de Lima VMF
    Comp Immunol Microbiol Infect Dis; 2018 Apr; 57():1-7. PubMed ID: 30017072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis.
    Portela ÁSB; Costa LE; Salles BCS; Lima MP; Santos TTO; Ramos FF; Lage DP; Martins VT; Caligiorne RB; Lessa DR; Silva FR; Machado AS; Nascimento GF; Gama IS; Chávez-Fumagalli MA; Teixeira AL; Rocha MOC; Rocha RL; Coelho EAF
    Immunobiology; 2018 Mar; 223(3):303-309. PubMed ID: 29074301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoprophylactic Potential of a New Recombinant
    Pessoa-E-Silva R; Trajano-Silva LAM; Vaitkevicius-Antão V; Dos Santos WJT; Magalhães FB; Moura DMN; Nakasone EKN; de Lorena VMB; de Paiva-Cavalcanti M
    Front Immunol; 2020; 11():605044. PubMed ID: 33488607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of pro-inflammatory cytokines and iron regulatory protein 2 (IRP2) with Leishmania burden in canine visceral leishmaniasis.
    do Nascimento PR; Martins DR; Monteiro GR; Queiroz PV; Freire-Neto FP; Queiroz JW; Morais Lima AL; Jeronimo SM
    PLoS One; 2013; 8(10):e73873. PubMed ID: 24146743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis.
    Carrillo E; Crusat M; Nieto J; Chicharro C; Thomas Mdel C; Martínez E; Valladares B; Cañavate C; Requena JM; López MC; Alvar J; Moreno J
    Vaccine; 2008 Mar; 26(15):1902-11. PubMed ID: 18321614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Splenic immune responses during canine visceral leishmaniasis.
    Strauss-Ayali D; Baneth G; Jaffe CL
    Vet Res; 2007; 38(4):547-64. PubMed ID: 17540157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine expression in dogs with natural Leishmania infantum infection.
    Panaro MA; Brandonisio O; Cianciulli A; Cavallo P; Lacasella V; Paradies P; Testini G; De Caprariis D; Mitolo V; Otranto D
    Parasitology; 2009 Jul; 136(8):823-31. PubMed ID: 19490725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of miRNAs in canine peripheral blood mononuclear cells (PBMC) exposed to Leishmania infantum in vitro.
    Soares MF; Melo LM; Bragato JP; Furlan AO; Scaramele NF; Lopes FL; Lima VMF
    Res Vet Sci; 2021 Jan; 134():58-63. PubMed ID: 33302213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs.
    Fiuza JA; Santiago Hda C; Selvapandiyan A; Gannavaram S; Ricci ND; Bueno LL; Bartholomeu DC; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2013 Apr; 31(14):1785-92. PubMed ID: 23398933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Overview of Immunotherapeutic Approaches Against Canine Visceral Leishmaniasis: What Has Been Tested on Dogs and a New Perspective on Improving Treatment Efficacy.
    Gonçalves AAM; Leite JC; Resende LA; Mariano RMDS; Silveira P; Melo-Júnior OAO; Ribeiro HS; de Oliveira DS; Soares DF; Santos TAP; Marques AF; Galdino AS; Martins-Filho OA; Dutra WO; da Silveira-Lemos D; Giunchetti RC
    Front Cell Infect Microbiol; 2019; 9():427. PubMed ID: 31921703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous immune mechanisms in canine leishmaniosis due to Leishmania infantum.
    Papadogiannakis EI; Koutinas AF
    Vet Immunol Immunopathol; 2015 Feb; 163(3-4):94-102. PubMed ID: 25555497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.